Free shipping on orders over $99*

Orders placed April 6-20 may take longer to ship due to the Passover Holiday

For visual reference only; actual product may vary

  • US Name:

    Sotyktu

  • Alternative Names:

    Sotyktu

  • Active Ingredients:

    Deucravacitinib

  • Brand Manufacturer:

    Bristol Myers Squibb

  • Manufacturer Location:

    USA

  • Click here to view Product Insert

  • Click here to view Product Insert

Sotyktu *

For visual reference only; actual product may vary

Prescription Required
All third-party products, company names, and logos are trademarks™ or registered® trademarks are and remain the property of their respective holders. Their use does not imply any affiliation with or endorsement by them. All references on this site to third-party trademarks are intended to constitute nominative fair use under applicable trademark laws.

Sotyktu is prescribed for the treatment of moderate to severe plaque psoriasis in adults.

Place your order

Sotyktu Brand 6mg
28 Tablets
-
+
Our price:
$1,100.00

*Please note all prices are in US dollars
Sotyktu (generic name: deucravacitinib) is an oral medication prescribed for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Deucravacitinib is a selective inhibitor of tyrosine kinase 2 (TYK2), an enzyme that plays a pivotal role in the inflammatory pathways associated with psoriasis. By inhibiting TYK2, deucravacitinib disrupts the signaling of cytokines such as interleukin-12 (IL-12) and interleukin-23 (IL-23), which are involved in the inflammatory process of psoriasis. This targeted inhibition helps reduce the overactive immune response characteristic of the condition. Deucravacitinib belongs to the class of medications known as TYK2 inhibitors, which are a subset of the broader category of Janus kinase (JAK) inhibitors. However, deucravacitinib’s selective inhibition of TYK2 differentiates it from other JAK inhibitors, offering a distinct safety and efficacy profile. Sotyktu represents a significant advancement in the treatment of moderate to severe plaque psoriasis by selectively targeting TYK2. Its oral administration offers convenience, and its mechanism provides a targeted approach to managing the inflammatory processes underlying psoriasis. 

Dosage and Administration

The standard dosage for Sotyktu is 6 mg taken orally once daily. Patients can take the tablet with or without food, according to their preference. It is important to swallow the tablet whole; patients should not crush, cut, or chew it. If a patient misses a dose of Sotyktu, they should take the missed dose as soon as they remember. However, if it is almost time for the next scheduled dose, they should skip the missed dose and resume their regular dosing schedule. Patients should not double-dose to make up for a missed dose.

Storage

Sotyktu should be stored at room temperature, between 68°F to 77°F (20°C to 25°C). It is important to keep the medication in its original container, tightly closed, and away from moisture and heat. Patients should also ensure that Sotyktu is kept out of reach of children.

Common Questions About Sotyktu

How does deucravacitinib work?
Deucravacitinib selectively inhibits the tyrosine kinase 2 (TYK2) enzyme, which plays a role in the inflammatory pathways associated with psoriasis. By inhibiting TYK2, it helps reduce the overactive immune response characteristic of the condition.
What is plaque psoriasis?
Plaque psoriasis is a chronic autoimmune condition characterized by the rapid buildup of skin cells, leading to the formation of scales and red patches that can be itchy and sometimes painful.
How do TYK2 inhibitors differ from other psoriasis treatments?
TYK2 inhibitors, like Sotyktu, offer a targeted approach by selectively inhibiting the TYK2 enzyme involved in the inflammatory process of psoriasis, potentially offering a distinct safety and efficacy profile compared to other treatments.

This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication. 

Read the information leaflet that comes with the medication.

Most people who use Sotyktu do not experience any adverse side effects. Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.

Some of the side effects that have been reported include:

  • Upper respiratory tract infections
  • Herpes simplex infections
  • Folliculitis
  • Acne
  • Headache
  • Diarrhea and nausea
  • Hypertension
  • Back pain and joint pain
  • Fatigue

Not all side effects are listed here. If these or other unlisted symptoms persist or worsen, consult a healthcare provider or pharmacist.

Sotyktu is approved for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Plaque Psoriasis

Plaque psoriasis is a chronic autoimmune condition characterized by the rapid buildup of skin cells, leading to the formation of scales and red patches that can be itchy and sometimes painful. Common symptoms include:

  • Red patches of skin covered with thick, silvery scales
  • Dry, cracked skin that may bleed
  • Itching, burning, or soreness
  • Thickened or ridged nails
  • Swollen and stiff joints

Sotyktu works by inhibiting TYK2, thereby reducing the inflammatory activity that leads to these symptoms.

  • What are TYK2 inhibitors?
    TYK2 inhibitors are a class of medications that selectively inhibit the tyrosine kinase 2 (TYK2) enzyme, which plays a role in the inflammatory pathways associated with certain autoimmune conditions, including psoriasis.
  • How does Sotyktu help in managing plaque psoriasis?
    Sotyktu helps reduce the overactive immune response characteristic of plaque psoriasis by selectively inhibiting the TYK2 enzyme, which plays a role in the inflammatory pathways associated with the condition.
  • How long does it take for Sotyktu to show results in plaque psoriasis treatment?
    The time it takes to see possible results with Sotyktu will vary from person to person. In one clinical trial, half of the people taking Sotyktu saw clear or almost clear skin at 4 months.
  • Can deucravacitinib be used during pregnancy?
    There is limited information on the use of deucravacitinib during pregnancy. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Getting started with IsraelPharm

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Generally 7-10 Business Days

Fast delivery
Secure payment
Genuine brands
Pharmacist oversight
Proudly Israeli

Ordering is
simple and safe.

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Read more from our blog

impact of PBM control on drug prices

Drug Prices Up Retail Pharmacies Down

Three major problems are putting America’s prescription drug supply in danger. First, health insurance companies are quietly controlling drug supply chains to make more money for themselves. Second, more pharmacies are shutting down, leaving many communities, impoverished

Read More »
What are the most common midlife eating problems

Yes, Midlife Eating Disorders Are Real

Many people think eating disorders are only a problem for teenagers or young adults. They believe conditions like anorexia, bulimia, binge eating disorder, and other similar behaviors happen to younger women dealing with body changes

Read More »

Login

Fast Delivery
Ships from Israel
Secure Payment
Genuine Brands
Pharmacist Oversight
Proudly Israeli
Free Shipping on orders over $99*

Having issues?

Daily from 9am-8pm EST.
IsraelPharm c/o SUBS Ltd. Ha'Uman 5 Bet Shemesh Israel, 9906105

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email